The winners — Bengaluru-based BioCipher Labs, Prodancy and Kochi-based Mykare.ai — were selected after shortlisted startups pitched their solutions to mentors, investors and cohort guides from India and Israel, according to a press release.
BioCipher Labs develops AI-powered molecular diagnostics, while Prodancy has developed an indigenous surgical helmet for joint replacement procedures aimed at replacing imported consumables. Mykare.ai is an AI-native patient management platform for clinics and smaller hospitals.
The three startups will receive a fully funded, week-long immersive programme in Israel, where they will engage with the country’s healthcare and innovation ecosystem and explore opportunities to validate, scale and take their businesses to global markets.
HealthSprint 2026 received 175 applications, with 15 startups — five each across Diagnose, Treat and Manage categories — shortlisted to pitch before investors, mentors and industry experts.
Max Shmagin, deputy consul general, Consulate General of Israel for South India in Bengaluru, said collaboration between India and Israel in healthcare could help validate and scale solutions across both markets.
Girish Hiremath, COO, GINSERV, said the programme brought Indian founders directly in contact with Israel’s clinical validation capabilities.Dr CN Manjunath, Bangalore Rural MP and former director of Sri Jayadeva Institute of Cardiovascular Sciences and Research, said healthcare innovation needed to remain affordable and accessible.
The programme also featured mentors and investors from Israel, including Benjamin Dekel of Sheba Medical Centre, Talor Sax of eHealth Ventures and Nimrod Mon Brokman of Behavioral Foresight, who emphasised clinical validation, fundable milestones and the ability of founders to learn from failure and adapt.I can also make this more sharply business-focused, with greater emphasis on funding, investability and the India-Israel healthcare opportunity, the release added.
